Jonathan T.
- Country
- France
- Department
- Oncology
Research Overview
- Phase III Evaluation of Acetylsalicylic Acid and Atorvastatin on Overall Survival in Castration-Resistant Prostate Cancer Patients
- Efficacy Comparison of Nivolumab-Ipilimumab Versus Immune Checkpoint Inhibitor-VEGFR TKI Combinations in Untreated Metastatic Renal Cell Carcinoma
- Phase III Randomized Trial of Intermittent vs. Continuous Androgen Deprivation Therapy with AR Pathway Inhibitors in Metastatic Hormone-Naïve Prostate Cancer
Data & Insights
Has run more than one trial at 99 of 304 partner sites.
Specializations
Urological Oncology
This investigator specializes in advanced prostate cancer treatments, with particular focus on castration-resistant prostate cancer and metastatic prostate cancer management. Their research encompasses innovative therapeutic approaches including hormone therapy and novel drug combinations.
- Androgen Deprivation Therapy (ADT)
- Novel therapeutic combinations
- Metastatic disease management
Head and Neck Cancer
The investigator conducts research in head and neck squamous cell carcinoma and adenoid cystic carcinoma. Their work includes studies of immunotherapy approaches and targeted treatments for recurrent and metastatic disease.
- HPV-positive oropharyngeal cancer
- Immunotherapy combinations
- Advanced disease treatment
Multi-Cancer Research
Their expertise extends to various solid tumors including renal cell carcinoma and gynecological cancers. The investigator focuses on immune checkpoint inhibitor therapies and novel treatment combinations.
- Metastatic kidney cancer
- Urothelial carcinoma
- Gynecological malignancies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.